Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Insight Molecular Diagnostics (IMDX) Depreciation & Amortization (IS): 2024-2025

Historic Depreciation & Amortization (IS) for Insight Molecular Diagnostics (IMDX) over the last 2 years, with Sep 2025 value amounting to $584,000.

  • Insight Molecular Diagnostics' Depreciation & Amortization (IS) rose 71.76% to $584,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $1.6 million for FY2024, which is 6.90% down from last year.
  • Per Insight Molecular Diagnostics' latest filing, its Depreciation & Amortization (IS) stood at $584,000 for Q3 2025, which was up 4.47% from $559,000 recorded in Q2 2025.
  • Over the past 5 years, Insight Molecular Diagnostics' Depreciation & Amortization (IS) peaked at $584,000 during Q3 2025, and registered a low of $326,000 during Q2 2024.
  • Its 2-year average for Depreciation & Amortization (IS) is $456,857, with a median of $491,000 in 2025.
  • Data for Insight Molecular Diagnostics' Depreciation & Amortization (IS) shows a peak YoY surged of 71.76% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Insight Molecular Diagnostics' Depreciation & Amortization (IS) stood at $563,000 in 2024, then soared by 71.76% to $584,000 in 2025.
  • Its last three reported values are $584,000 in Q3 2025, $559,000 for Q2 2025, and $491,000 during Q1 2025.